James Hardie Industries (JHX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jan, 2026Executive summary
Delivered strong Q3 FY25 results with net sales of $953 million, down 3% year-over-year, and adjusted EBITDA of $262 million (27.5% margin), down 7%, while reaffirming FY25 and FY26 growth plans and focusing on margin expansion and innovation.
Maintained robust performance and operational execution despite challenging demand and raw material headwinds, with continued investments in capacity and customer partnerships.
Outperformed end markets in North America, supported by strategic investments and a focus on long-term value creation through material conversion and demand generation.
Emphasized safety, sustainability, and operational efficiency through the Hardie Operating System (HOS).
Financial highlights
Q3 FY25 net sales were $953 million, down 3% year-over-year; adjusted EBITDA was $262 million (27.5% margin), down 7%; adjusted net income was $154 million, down 15%; adjusted diluted EPS was $0.36.
North America: Net sales $719 million (down 1%), EBIT margin 29.1%, ASP up 2%, volume down 3%.
Asia-Pacific: Net sales $118 million (down 12%), driven by 28% volume drop from Philippines exit, offset by 20% ASP rise; EBIT margin 29.3%.
Europe: Net sales $116 million (down 1%), high-value product sales grew double digits; EBIT margin 3.1%, EBITDA margin 10.3%.
Nine months FY25: Net sales $2.91 billion, adjusted EBITDA $811 million (27.9% margin), operating cash flow $657 million, capex $333 million, share repurchases $150 million.
Outlook and guidance
FY25 guidance reaffirmed: North America volume at least 2.95bnsf, EBIT margin at least 29.3%, adjusted net income at least $635 million, and capex ~$420 million.
FY26 planning assumes sales and adjusted EBITDA growth and margin expansion across all regions, with double-digit North America net sales growth and 500bps EBITDA margin expansion vs. FY24.
Latest events from James Hardie Industries
- Q3 FY26 sales up 30% with higher EBITDA and synergy gains, but net income declined.JHX
Q3 202611 Feb 2026 - Q2 FY26 sales jumped 34% on AZEK deal; margins fell, but FY26 outlook and synergies improved.JHX
Q2 20263 Feb 2026 - Q1 FY25 delivered record EBITDA, strong margins, and reaffirmed guidance amid market challenges.JHX
Q1 20252 Feb 2026 - H1 EBITDA topped $500m, FY25 guidance and buybacks raised despite lower sales.JHX
Q2 202514 Jan 2026 - FY25 met guidance; AZEK deal to drive $500M synergies; FY26 targets sales, EBITDA, and cash flow growth.JHX
H2 202514 Jan 2026 - $8.75B merger targets $350M in synergies and forms a top building products growth platform.JHX
Business Combination27 Dec 2025 - Q1 FY26 sales fell 9%, AZEK acquisition closed, and early synergies are being realized.JHX
Q1 202623 Nov 2025 - Director re-elections and remuneration proposals faced rejection, while equity plans passed.JHX
AGM 202530 Oct 2025 - Merger with AZEK accelerates growth and market expansion through synergy and innovation.JHX
Jefferies Mining and Industrials Conference 202520 Oct 2025